Rechallenge Decisions
Rechallenge Decisions is a clinical decision-making framework in hypersensitivity reaction management within multidisciplinary cardio-oncology care that determines the safety and appropriateness of reintroducing a previously implicated therapeutic agent after an adverse reaction, based on risk stratification, multidisciplinary evaluation, and patient-specific factors.
5
Publications
506
Citations
36
Authors
25
Institutions
Publications per year
2017–2026
2
5
Severe cutaneous adverse reactions due to inappropriate medication use
G. Chaby, L. Valeyrie‐Allanore, T.A. Duong et al. · British Journal of Dermatology · 2018 · 25 citations
Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment
Cancer Management and Research · 2022 · 24 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 5
36
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 36
25
Hôpital Saint-André
Bordeaux, France
1 h-index
1 publications
25 citations

The University of Melbourne
Melbourne, Australia
1 h-index
4 publications
88 citations
Université Paris-Est Créteil
Créteil, France
1 h-index
5 publications
125 citations
Hôpital Charles-Nicolle
Rouen, France
1 h-index
1 publications
25 citations
National Institute of Diabetes and Digestive and Kidney Diseases
Bethesda, United States
1 h-index
3 publications
969 citations
University of Michigan
Ann Arbor, United States
1 h-index
1 publications
323 citations
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
Madrid, Spain
1 h-index
1 publications
323 citations

McMaster University Medical Centre
Hamilton, Canada
1 h-index
1 publications
103 citations
1–8 of 25
1 publications · 33 citations
1
h-index
CJP · 1 publications · 22 citations
1
h-index
Repository · 1 publications · 103 citations
1
h-index
1 publications · 323 citations
1
h-index
1 publications · 25 citations
1
h-index
1–5